Nobuhito Taniki

2PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 05, 2026
Early Changes in Lymphocyte Counts Predict Clinical Outcomes in Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab.

|Jan 17, 2026
Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate-Stage Hepatocellular Carcinoma: A Multicenter Cohort Study.

Nobuhito Taniki, Keisuke Ojiro, Ryosuke Kasuga

Pageof 1

Frequent Collaborators

2 joint publications

Nobuhiro Nakamoto

1 joint publications

Keisuke Ojiro

1 joint publications

Jitsuro Tsukada

1 joint publications

Yasushi Hasegawa